Effect of Teriparatide on Femoral Neck Fracture Healing.

Trial Profile

Effect of Teriparatide on Femoral Neck Fracture Healing.

Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Hip fracture
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 23 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
    • 28 Feb 2013 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 28 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top